Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madle

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Mutation Research|October 1, 1981
Evaluation of experimental parameters in an S9 /human leukocyte SCE test with cyclophosphamideS Madle
Mutation Research|July 1, 1994
Strategies and philosophies of genotoxicity testing: highly sophisticated versus pragmatic regulatory approaches (reply to Zeiger (1994), strategies and philosophies of genotoxicity testing: what is the question?)S Madle
Mutation Research|July 1, 1993
Problem of the harmonization of philosophies for genotoxicity testingS Madle
Mutation Research|February 1, 1993
Assessment and evaluation of genotoxicity findingsS Madle, R Lang
Mutation Research|September 1, 1977
In vitro testing of an indirect mutagen (cyclophosphamide) with human leukocyte cultures: activation with liver microsomes and use of a dialysis bagS Madle, G Obe
Arzneimittel-Forschung|January 1, 1981
The use of rat liver perfusion to detect indirect mutagens/carcinogens in human leukocytes in vitroS Madle, G Obe
Human Genetics|January 1, 1980
Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cellsS Madle, G Obe
Mutation Research|January 1, 1978
In vitro testing of an indirect mutagen (cyclophosphamide) with human leukocyte cultures. Activation by a non-enzymatic hydroxylation system (Udenfriend system)S Madle, G Obe
Mutation Research|August 1, 1987
Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agencyS Madle, A Korte, R Bass
Mutagenesis|March 1, 1991
The quality of genotoxicity testing of drugs. Experiences of a regulatory agency with new and old compoundsL Müller, P Kasper, S Madle
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Mutation Research|October 1, 1981
Evaluation of experimental parameters in an S9 /human leukocyte SCE test with cyclophosphamideS Madle
Mutation Research|July 1, 1994
Strategies and philosophies of genotoxicity testing: highly sophisticated versus pragmatic regulatory approaches (reply to Zeiger (1994), strategies and philosophies of genotoxicity testing: what is the question?)S Madle
Mutation Research|July 1, 1993
Problem of the harmonization of philosophies for genotoxicity testingS Madle
Mutation Research|February 1, 1993
Assessment and evaluation of genotoxicity findingsS Madle, R Lang
Mutation Research|September 1, 1977
In vitro testing of an indirect mutagen (cyclophosphamide) with human leukocyte cultures: activation with liver microsomes and use of a dialysis bagS Madle, G Obe
Arzneimittel-Forschung|January 1, 1981
The use of rat liver perfusion to detect indirect mutagens/carcinogens in human leukocytes in vitroS Madle, G Obe
Human Genetics|January 1, 1980
Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cellsS Madle, G Obe
Mutation Research|January 1, 1978
In vitro testing of an indirect mutagen (cyclophosphamide) with human leukocyte cultures. Activation by a non-enzymatic hydroxylation system (Udenfriend system)S Madle, G Obe
Mutation Research|August 1, 1987
Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agencyS Madle, A Korte, R Bass
Mutagenesis|March 1, 1991
The quality of genotoxicity testing of drugs. Experiences of a regulatory agency with new and old compoundsL Müller, P Kasper, S Madle
Pageof 4